Food News and Research

RSS

FDA approves BioAlliance Pharma's Oravig for OPC

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today the approval by the US FDA of Oravig® (miconazole Lauriad®, known as Loramyc® in Europe) for the treatment of Oropharyngeal Candidiasis (OPC) in adults.

17 Apr 2010

Nine-year-old cancer patient benefits from procedure to magnetically extend her leg

Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows. The implant and extension took place at Texas Children's Cancer Center in Houston, Texas.

16 Apr 2010

Repligen expects total revenue of $21.0M for fiscal year 2010

Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.

16 Apr 2010

Second Annual Superhero event to drive awareness for child abuse prevention

It's a bird, it's a plane - yes, that's Superman making his way through North Park along with the rest of his Super Friends in the Second Annual Superhero 5K/1K Run/Walk, a unique event designed to drive awareness for child abuse prevention and support organizations that rehabilitate and heal the victims of abuse.

16 Apr 2010

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Findings published today in The New England Journal of Medicine from a first-of-its-kind comparator trial evaluating the anti-tumor necrosis factor (TNF)-alpha biologic treatment REMICADE (infliximab) in the treatment of moderately to severely active Crohn's disease in patients who were naive to immunomodulator and biologic therapy, showed that a significantly greater proportion of patients receiving REMICADE achieved steroid-free remission and mucosal healing compared with patients receiving azathioprine.

16 Apr 2010

Diabetic mice generate new insulin-producing cells following extreme cell destruction

Type 1 diabetes is the most common cause of diabetes in children, although it may occur at any age. Also called juvenile diabetes, this pathology usually results from autoimmune destruction of insulin-producing cells of the pancreas.

16 Apr 2010

UDH to participate in Abbott's new PLEX-ID BPEP

Abbott today announced that the Utah Department of Health is one of five sites in the United States to participate in Abbott's new PLEX-ID Biopreparedness Evaluation Program, which involves Abbott, the Association of Public Health Laboratories and five state public health labs.

16 Apr 2010

ASH named fourth healthiest large-group business employer in San Diego county

American Specialty Health Incorporated (ASH), a leading national health and wellness organization, announced that it was named the fourth healthiest large-group business in San Diego county in the first annual "San Diego's Healthiest Employers Awards," produced by the San Diego Business Journal. Certificates were presented to 50 finalists, and only the top five companies in small, medium, and large categories were named as honorees.

16 Apr 2010

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).

16 Apr 2010

Melamine concentrations in eggs do not exceed FDA limits

Eggs from chickens that consumed extremely high levels of melamine in their feed still did not contain levels of the potentially toxic contaminant that exceeded U. S. Food and Drug Administration (FDA) limits.

16 Apr 2010

Laquinimod may have neuroprotective properties in addition to anti-inflammatory effects for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from several studies demonstrating that laquinimod, a novel, investigational once-daily oral immunomodulator for relapsing remitting multiple sclerosis (RRMS) may have neuroprotective properties in addition to its anti-inflammatory effects.

16 Apr 2010

1440 nm wavelength beneficial in laser-assisted lipolysis for fat-disruption and tissue tightening

Cynosure, Inc. today announced the presentation of a new study that demonstrates the clinical benefits of using a 1440 nm wavelength in laser-assisted lipolysis to disrupt fat tissue and tighten skin through tissue coagulation. The study, led by Barry DiBernardo, M.D., Medical Director of New Jersey Plastic Surgery, is one of six Cynosure-related abstracts being presented this week at the 2010 American Society for Laser Medicine and Surgery (ASLMS) Annual Conference in Arizona.

16 Apr 2010

Flavonoids of onion are natural alternative to artificial additives in food industry: Study

Some components of the onion have antioxidant and antimicrobial properties, making it possible to use this bulb for food preservation. This is demonstrated by researchers from the Polytechnic University of Catalu-a and the University of Barcelona in a study that has just been published in the International Journal of Food Science and Technology.

16 Apr 2010

Cequent Pharmaceuticals commences toxicology study of CEQ508 tkRNAi-based therapeutic candidate

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 – the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps and in the progression of polyps to colorectal cancer.

16 Apr 2010

FDA grants marketing clearance for Cambridge Heart's MTWA OEM module

Cambridge Heart, Inc., today announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Microvolt T-Wave Alternans (MTWA) OEM module. The MTWA OEM module is designed to work with existing cardiac stress test platforms distributed by other manufacturers. This FDA 510(k) clearance allows Cambridge Heart to begin marketing the MTWA OEM module integrated with the Q-Stress line of stress systems manufactured by Cardiac Science Corporation, Inc..

16 Apr 2010

Escherichia coli cases drop in 2009

As per a report from the Centers for Disease Control and Prevention (CDC) a 12 % drop in rates of Escherichia coli (E.coli) infection has been noted in 2009 as compared to statistics for 2008. This is being seen by federal health officials as a sign that the new food safety measures are effective. Most of the pathogens under study are from the bacteria family like E.coli 0157, salmonella, campylobacter, listeria and vibrio. It was found that food poisoning rates for the most common pathogens have changed little from statistics collected in 2004.

16 Apr 2010

To ban or not to ban trans fats

Now it is doctors too who have joined the move towards banning trans fats from food. Trans fats are hydrogenated solid fats that are found in deep fried foods, margarine, bakery products, fast foods etc. they are used because they are cheap and keep better. However it has long been known that these fats are bad for the heart leading to heart attacks, strokes and high blood cholesterol etc.

16 Apr 2010

UALR researcher receives federal grant to track estrogen-mimicking compounds in consumer products

Dr. Jerry Darsey, professor of chemistry in UALR's College of Science and Mathematics, has received $77,000 from a federal Food and Drug Administration grant to develop methods to track estrogen mimicking compounds in various products and assess how use of the products affect women.

16 Apr 2010

IFT offers support for President's Task Force on Childhood Obesity

In comments delivered to the Obama Administration, the Institute of Food Technologists today offered its support for the President's Task Force on Childhood Obesity and efforts by First Lady Michelle Obama designed to raise awareness on the critical issue of childhood obesity.

16 Apr 2010

IBA's PBS system for Proton Therapy granted CE Mark

IBA's second generation Pencil Beam Scanning system for Proton Therapy, which further enhances the performance of anti-cancer proton treatments, has been granted the CE Mark, certifying that the product has met European Union medical device regulations.

16 Apr 2010

Food News and Research

FDA approves BioAlliance Pharma's Oravig for OPC

Nine-year-old cancer patient benefits from procedure to magnetically extend her leg

Repligen expects total revenue of $21.0M for fiscal year 2010

Second Annual Superhero event to drive awareness for child abuse prevention

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Diabetic mice generate new insulin-producing cells following extreme cell destruction

UDH to participate in Abbott's new PLEX-ID BPEP

ASH named fourth healthiest large-group business employer in San Diego county

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Melamine concentrations in eggs do not exceed FDA limits

Laquinimod may have neuroprotective properties in addition to anti-inflammatory effects for RRMS

1440 nm wavelength beneficial in laser-assisted lipolysis for fat-disruption and tissue tightening

Flavonoids of onion are natural alternative to artificial additives in food industry: Study

Cequent Pharmaceuticals commences toxicology study of CEQ508 tkRNAi-based therapeutic candidate

FDA grants marketing clearance for Cambridge Heart's MTWA OEM module

Escherichia coli cases drop in 2009

To ban or not to ban trans fats

UALR researcher receives federal grant to track estrogen-mimicking compounds in consumer products

IFT offers support for President's Task Force on Childhood Obesity

IBA's PBS system for Proton Therapy granted CE Mark

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News